CareDx, Inc.: CareDx Announces Cibiltech Initiates CIBIL Study Using iBox Artificial Intelligence to Monitor Kidney Transplant Patients
Results from CareDx's OKRA Study and Cibiltech's CIBIL Study will Demonstrate Clinical Utility of iBox for Transplant Patient ManagementSOUTH SAN FRANCISCO, Calif., March 03, 2022 (GLOBE NEWSWIRE) -- CareDx